BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2005
View Archived Issues
Oragenics develops manufacturing process for Mutacin 1140
Read More
Labedipinedilol A: a potential treatment for atherosclerosis
Read More
A novel vasopressin V1b receptor antagonist reduces aggressive behavior
Read More
NPY Y2 receptor is involved in PYY3-36-mediated appetite regulation / News in Context
Read More
CH-1504 in development at Chelsea Therapeutics for rheumatoid arthritis
Read More
Pfizer reviews recent developments
Read More
A transdermal testosterone patch improves androgen deficiency in women with POF / News in Context
Read More
Avigen discontinues AAV funding to focus on traditional pharmaceuticals
Read More
Pfizer to suspend Bextra in Europe, Canada
Read More
Phase II trial studies Ceflatonin in combination with Gleevec for CML
Read More
Abbott cleared to begin ZOMAXX II trial
Read More
Array BioPharma and Genentech expand oncology collaboration
Read More
Ligand exercises final option to buy down Ontak royalties
Read More
AVE-1330A effective against ceftazidime-resistant Enterobacteriaceae species
Read More
New phase I data on the safety and pharmacokinetics of PTC-124
Read More
BG-12 reduces symptom scores in moderate-severe psoriasis
Read More
AVE-4221 effective against methicillin and multidrug resistant strains of Staphylococcus aureus
Read More
XP-13512 shows promise in the treatment of PHN
Read More
Emtriva and Truvada set for Japanese launch
Read More
Oxypurinol reported to improve ejection fraction of CHF patients
Read More
BrachySil enters full development program for pancreatic cancer
Read More
Tracleer receives Japanese approval
Read More
Novel therapeutic agents for obesity reported by Schering-Plough
Read More
Recent patents disclose novel agents for the treatment of infectious diseases
Read More
New Japanese approval for Prograf
Read More
BLA filing for RotaTeq
Read More
Yondelis receives orphan drug designation for ovarian cancer
Read More